Economic burden of systemic sclerosis: systematic review by D. L. Klabukova, V. S. Krysanova, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin

Get full text

Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the M... by A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin

Get full text

ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES by V. S. Krysanova, E. D. Ermolaeva, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin

Get full text

Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome by O. I. Ivakhnenko, E. V. Derkach, V. S. Krysanova, A. D. Ermolaeva, K. A. Kokushkin

Get full text

Safety of generic fingolimod by O. M. Koval, N. V. Khachanova, M. V. Zhuravleva, A. G. Fisun, M. V. Davydovskaya, K. A. Kokushkin

Get full text

Economic aspects of the fixed combinations of lipid lowering medicines in group risks patients by M. V. Zhuravleva, M. Yu. Frolov, E. A. Luchinin, K. A. Kokushkin, E. D. Laryushkina, T. R. Kameneva, E. V. Kuznetsova

Get full text

Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review by D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin

Get full text

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review by D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, E. M. Olyushina, K. I. Polyakova, A. G. Fisun, M. G. Grinin, K. A. Kokushkin

Get full text